Skip to main content

FDA Approves Long-Awaited Cholesterol Drugs

Federal regulators have signed off on a new drug that lowers cholesterol, a development that could bring an important but costly new medical tool to fighting heart disease.

Republish
Lead image for this article

Federal regulators have signed off on a new drug that lowers cholesterol, a development that could bring an important but costly new medical tool to fighting heart disease. The drugs — which could benefit millions — are an alternative to the much-cheaper statins, the common cholesterol-lowering drug that might not be adequate for some. (Wall Street Journal) 

Texans need truth. Help us report it.

Our Fall Member Drive is underway, and we need your support. The Texas Tribune is a critical source of truth and information for Texans across the state and beyond — and our community of members, the readers who donate, make our work possible. Will you join as a member with a tax-deductible donation of any amount?

Yes, I'll donate today

Information about the authors

Explore related story topics